格隆汇5月23日丨健世科技-B(09877.HK)公告,近期,LuX-Valve Plus经血管三尖瓣介入置换(TTVR)系统的全球多中心临床试验("TRINITY")30天临床随访结果以及JensClip经血管二尖瓣修复(TMVr)系统一年期随访结果于法国巴黎举办的EuroPCR2025上正式发布。 TRINITY是一项全球前瞻性、多中心、单臂临床试验,主要用于评估LuX-ValvePlus于...
Source Link格隆汇5月23日丨健世科技-B(09877.HK)公告,近期,LuX-Valve Plus经血管三尖瓣介入置换(TTVR)系统的全球多中心临床试验("TRINITY")30天临床随访结果以及JensClip经血管二尖瓣修复(TMVr)系统一年期随访结果于法国巴黎举办的EuroPCR2025上正式发布。 TRINITY是一项全球前瞻性、多中心、单臂临床试验,主要用于评估LuX-ValvePlus于...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.